Accepted for Publication: March, 2012.
Published Online: May 21, 2012. doi:10.1001/archdermatol.2012.983
Authors Contributions: All authors had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Sagransky and Quandt. Acquisition of data: Pichardo-Geisinger, Muñoz-Ali, Feldman, Mora, and Quandt. Analysis and interpretation of data: Pichardo-Geisinger, Muñoz-Ali, and Feldman. Drafting of the manuscript: Sagransky, Mora, and Quandt. Critical revision of the manuscript for important intellectual content: Sagransky, Pichardo-Geisinger, Muñoz-Ali, Feldman, and Mora. Administrative, technical, and material support: Mora and Quandt. Study supervision: Quandt.
Financial Disclosure: Dr Quandt has received grants from Galderma, Stiefel/GSK, Astellas, Abbott Labs, Centocor/Janssen, Amgen, Photomedex, Coria/Healthpoint/Valeant, Pharmaderm/Nycomed, Medicis, National Psoriasis Foundation, Ortho Pharmaceuticals, Aventis Pharmaceuticals, Roche Dermatology, 3M, Bristol-Myers Squibb Dermatology, Novartis, Merck, Suncare Reearch, Leo/Peplin, Medscape, Kikaku, Caremark, Warner Chilcott, Hanall Pharma, and Medical Quality Enhancement Corp.
Funding/Support: Dr Feldman received funding from the National Institute for Occupational Safety and Health (grant No. R01 OH009251).